ABL Diagnostics Société anonyme Reports Full Year 2024 Earnings

ABL Diagnostics Société anonyme (EPA:ABLD) Full Year 2024 Results

Key Financial Results

• Revenue: €6.22m (flat on FY 2023).
• Net income: €285.2k (up 425% from FY 2023).
• Profit margin: 4.6% (up from 0.9% in FY 2023).

We've discovered 2 warning signs about ABL Diagnostics Société anonyme. View them for free.

All figures shown in the chart above are for the trailing 12 month (TTM) period

ABL Diagnostics Société anonyme Earnings Insights

Looking ahead, revenue is forecast to grow 36% p.a. on average during the next 2 years, compared to a 3.2% growth forecast for the Trade Distributors industry in France.

Performance of the French Trade Distributors industry.

The company's share price is broadly unchanged from a week ago.

Risk Analysis

Don't forget that there may still be risks. For instance, we've identified 2 warning signs for ABL Diagnostics Société anonyme that you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.